Exhibit 99

            CERTIFICATION OF CHIEF FINANCIAL OFFICER
               PURSUANT TO 18 U.S.C. SECTION 1350,
                     AS ADOPTED PURSUANT TO
          SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the IGENE Biotechnology, Inc. (the "Company")
Quarterly Report on Form 10-QSB for the period ended June 30,
2002, as filed with the Securities and Exchange Commission on the
date hereof (the "Report"), I, Edward J. Weisberger, Chief
Financial Officer of the Company, certify pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-
Oxley Act of 2002, that, to the best of my knowledge:

          (1). The Report fully complies with the requirements of
          Section 13(a) or 15(d) of the Securities Exchange Act
          of 1934, as amended; and

          (2). The information contained in the Report fairly
          presents, in all material respects, the financial
          condition and results of operations of the Company.


Date: August 14, 2002          By: /s/ EDWARD J. WEISBERGER
      ________________             ___________________________
                                       EDWARD J. WEISBERGER
                                       Chief Financial Officer